Clinical trial
Lanreotide In Polycystic Kidney Disease Study
NCT02127437 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Lanreotide In Polycystic Kidney Disease Study
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 19, 2014
- Completion date
- July 31, 2019
- Enrollment
- 159 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
autosomal dominant polycystic kidney disease (adpkd